You are here

Home › EU authorizes Novaax updated COVID vaccine for targeting JN.1 strain › EU authorizes Novaax updated COVID vaccine for targeting JN.1 strain

EU authorizes Novaax updated COVID vaccine for targeting JN.1 strain

Primary tabs

EU authorizes Novaax updated COVID vaccine for targeting JN.1 strain

Wed, 2024-10-09 12:18 — mike kraft

Novavax gets EU authorization for updated COVID vaccine targeting JN.1 strain

The European Commission authorized Novavax's (NVAX.O)

, opens new tab updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the company said on Wednesday.
The authorization is for use in individuals 12 years of age and older.
In August, the U.S. Food and Drug Administration granted emergency use authorization for Novavax's shot after approving vaccines made by Pfizer (PFE.N) , opens new tab and Moderna (MRNA.O), opens new tab.
...
Country / Region Tags: 
Europe
Global
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Mutations
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
Global Health
Europe
Vaccines
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks